Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 19/20 | 0.54 |
| ▸ | PRKDC | P78527 | 3/20 | 0.54 |
| ▸ | PIK3CA | P42336 | 14/20 | 0.51 |
| ▸ | MTOR | P42345 | 13/20 | 0.51 |
| ▸ | ATR | Q13535 | 3/20 | 0.51 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.46 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.46 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24221487 | 0.91 | ATM (0.48) | ATMPRKDCPIK3CAMTORATR | |
| SCHEMBL21513239 | 0.90 | ATM (0.61) | ATMPRKDCPIK3CAMTORATR | |
| SCHEMBL29968606 | 0.90 | ATM (0.61) | ATMPRKDCPIK3CAMTORATR | |
| SCHEMBL21851216 | 0.88 | ATM (0.49) | ATMPIK3CAMTORATRKCNH2 | |
| SCHEMBL21851163 | 0.87 | ATM (0.57) | ATMPRKDCPIK3CAMTORATR | |
| SCHEMBL21851057 | 0.86 | ATM (0.60) | ATMPRKDCPIK3CAMTORATR | |
| SCHEMBL21851114 | 0.86 | ATM (0.63) | ATMPRKDCPIK3CAMTORATR | |
| SCHEMBL21851110 | 0.86 | ATM (0.63) | ATMPRKDCPIK3CAMTORATR | |
| SCHEMBL21851105 | 0.85 | ATM (0.58) | ATMPRKDCPIK3CAMTORATR | |
| SCHEMBL21851103 | 0.84 | ATM (0.58) | ATMPRKDCPIK3CAMTORATR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3845532-B1 | QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF | MEDSHINE DISCOVERY INC (CN) | 2022-12-21 | — | — | EP | disclosed |
| US-20210380599-A1 | QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF | MEDSHINE DISCOVERY INC. (CN) | 2021-12-09 | — | — | US | disclosed |
| EP-3845532-A1 | QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF | Medshine Discovery Inc. (CN) | 2021-07-07 | — | — | EP | disclosed |
| WO-2020063855-A1 | QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF | 南京明德新药研发有限公司 | 2020-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210380599-A1 | QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF | ATM, CHEK2, CHEK1 | ATM 1/4885PRKDC 227/4885PIK3CA 870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.